Researchers have identified a new type of retinal ganglion cells.
A small group of retinal cells, known as OFF ganglion cells, can detect small dips in light levels and appear to be responsible for shadow detection.
Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
A new deep learning algorithm is superior to human experts in distinguishing between retinal ganglion cells in healthy patients and in those with glaucoma. The AI system could potentially help improve the diagnosis of both eye and brain diseases.
A newly developed system that uses OCT imaging and deep learning should enable better detection and monitoring of glaucoma.
Study supports the theory that highly specialized neurons in the brain are key to translating diverse visual stimuli into behavior.
Light sensitive cells in the fetal retina communicate as part of an interconnected network, giving the retina more light sensitivity during development that previously believed.
Study challenges the widely accepted belief that all light information is relayed through the suprachiasmatic nucleus, which synchronizes the circadian rhythm.
Gene therapy can restore the structure of the retina and regain normal light responses.
CT1 cells connect around 1400 areas in the fly brain. Each cell area works like a separate neuron, allowing CT1 to access information from the fly's eye and support local motion detection.
Gene therapy that targets retinal ganglion cells with light-sensitive cone opsins helps restore vision in mice. Researchers report a potential human treatment could be available within three years.
Researchers report signals from the retina are subjected to selective processing at the earliest neural way-station in the functional pathway connecting the retina to the visual cortex.
